Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001206774-14-001803
Filing Date
2014-05-28
Accepted
2014-05-28 17:20:23
Documents
2
Period of Report
2014-05-28

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES geron_form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES geron_form4.xml 4 3241
2 EXPLANATION OF RESPONSES exhibit99.htm EX-99 2281
  Complete submission text file 0001206774-14-001803.txt   7312
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Reporting) CIK: 0000886744 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-55046 | Film No.: 14873603
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390
Asterias Biotherapeutics, Inc. (Issuer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)